Search results for "Papillary"

showing 10 items of 146 documents

A pigmented papule acting like a playful ghost: dermoscopy of three targetoid hemosiderotic hemangiomas

2018

Targetoid hemosiderotic hemangioma represents an uncommon, distinctive, benign lympho-vascular lesion, with a variable clinical appearance, typically occurs in the lower limbs and trunk. Most patients are in their 20's or 30's. We describe three dermoscopic cases followed by the review of the literature. Dermoscopic images have been collected and have been evaluated for the presence of dermoscopic features. Concerning the review, we researched on pubmed and records were reviewed noting patient age of onset, sex, location, overall size, dermoscopic appearance. The harmonic mean age of patients was 31 years; the female-to-male ratio was 1:1, and the most common locations were lower extremitie…

Adultmedicine.medical_specialtySkin NeoplasmsTargetoid hemosiderotic hemangiomaDermoscopyDermatologyLesionDiagnosis Differential030207 dermatology & venereal diseases03 medical and health sciencesYoung Adult0302 clinical medicineDermismedicineHumanshemosiderotic hemangiomasbusiness.industryPapillary dermisEndothelial CellsPapuleClinical appearancemedicine.diseaseTrunkDermatologymedicine.anatomical_structureHomogeneous030220 oncology & carcinogenesisFemalemedicine.symptombusinessHemangioma
researchProduct

Detection of BRAFv600E mutation in papillary thyroid carcinoma using real time allele-specific amplification on fine needle aspiration biopsy specime…

2006

BRAF papillary thyroid carcinomaSettore MED/13 - Endocrinologia
researchProduct

BRAFV660E mutation and Timp-1 hyper-expression in classical variants of papyllary thyroid carcinoma.

2009

BrafV600E Papillary thyroid carcinoma TIMP-1Settore MED/13 - Endocrinologia
researchProduct

Thyroid Cancer Resistance to Chemotherapeutic Drugs via Autocrine Production of Interleukin-4 and Interleukin-10

2003

We investigated the mechanisms responsible for the widespread refractoriness to chemotherapeutic drugs observed in thyroid cancers. We show that malignant epithelial cells from papillary, follicular, and anaplastic thyroid carcinomas express high levels of Bcl-2 and Bcl-xL. Exogenous expression of either Bcl-2 or Bcl-xL in normal thyrocytes was sufficient to prevent chemotherapeutic drug-induced cytotoxicity. All of the histological thyroid cancer variants examined produced interleukin-4 (IL-4) and interleukin-10 (IL-10), which increased Bcl-2 and Bcl-xL levels and protected thyroid cells from chemotherapeutic agents. Exposure to neutralizing antibodies against IL-4 and IL-10 resulted in do…

Cancer ResearchCell DeathPaclitaxelCancer Research; OncologyCarcinomaThyroid Glandbcl-X ProteinAntineoplastic AgentsApoptosisThyroid Cancer Interleukin-4 Interleukin-10Middle AgedCarcinoma PapillaryInterleukin-10OncologyProto-Oncogene Proteins c-bcl-2Settore MED/04 - PATOLOGIA GENERALEDoxorubicinDrug Resistance NeoplasmHumansInterleukin-4Thyroid NeoplasmsCisplatinAged
researchProduct

Papillary Thyroid Microcarcinoma: Active Surveillance Against Surgery. Considerations of an Italian Working Group From a Systematic Review

2022

IntroductionActive surveillance is considered a viable option for papillary thyroid microcarcinoma. Since the last decade of the 20th century, this method has spread from Japan to other countries, but has not yet been fully accepted and validated by the major Western Scientific Societies. In 2016, a systematic review on the results of active surveillance was published, based on two articles that showed encouraging results. Other reviews published subsequently, were mainly based on articles from the Far East. The aim of this review is to assess the most recent results published from 2017 to 2020 on this subject.Materials and MethodsA systematic literature search was performed on MEDLINE via …

Cancer Researchlymph node metastasisquality of lifeOncologyactive surveillancethyroidectomythyroid cancerpapillary thyroid microcarcinomaFrontiers in Oncology
researchProduct

Chameleonic appearance of caseous calcification of the mitral valve – still a problem for its appropriate management

2021

According to the research literature, the caseous calcification of the mitral annulus (CCMA) is a rare variant of the mitral annulus calcification (MAC) entity, described mostly in elderly women. The aim of this study was to present the case of a 53-year-old female patient with caseous calcification of the mitral valve annulus and posterior cusp, which was diagnosed as papillary fibroelastoma. An echo-dense and quasi-homogeneous tumoral mass, measuring 1.6/1.4 cm, at the level of the posterior mitral ring was detected by echocardiographic examination, as well as by cardiac magnetic resonance imaging (MRI). Histopathological analysis revealed fibrous connective tissue with myxoid areas, hyal…

Embryologymedicine.medical_specialtyHeart Valve DiseasesCase ReportPathology and Forensic Medicinemitral calcificationCardiac magnetic resonance imagingMitral valvemedicineAnimalsHumanscaseous calcificationMitral Valve Annuluscardiovascular diseasesMitral annulusmedicine.diagnostic_testbusiness.industrymitral annulusCell BiologyGeneral MedicineMiddle Agedmedicine.diseaseFibrous connective tissuemyxoid structuremedicine.anatomical_structurePapillary fibroelastomacardiovascular systemMitral ValveFemaleRadiologyDifferential diagnosisbusinessDevelopmental BiologyCalcificationRomanian Journal of Morphology and Embryology
researchProduct

Diagnostic performance of endoscopic ultrasound through‐the‐needle microforceps biopsy of pancreatic cystic lesions: Systematic review with meta‐anal…

2020

Objectives Endoscopic ultrasound through-the-needle biopsy (EUS-TTNB) is a useful tool for differential diagnosis among pancreatic cystic lesions (PCLs). Cystic fluid cytology (CFC) is recommended by guidelines, but its diagnostic accuracy is about 50%. The aim of this meta-analysis is to assess the clinical impact of EUS-TTNB in terms of technical success (TS), histological accuracy (HA) and diagnostic yield (DY). Methods Original studies in English language on EUS-TTNB were searched in MEDLINE and EMBASE until October 2019. Diagnostic accuracy of EUS-TTNB for identification of mucinous PCLs was calculated using individual diagnostic data of patients who underwent CFC and surgery. Results …

Endoscopic ultrasoundmedicine.medical_specialtyserous cystadenomaEndosonographyhistologyCystic lesion03 medical and health sciences0302 clinical medicineBiopsymedicineHumansRadiology Nuclear Medicine and imagingCystAdverse effectEndoscopic Ultrasound-Guided Fine Needle AspirationPancreasIntraductal papillary mucinous neoplasmmedicine.diagnostic_testbusiness.industryIPMNintraductal papillary mucinous neoplasmGastroenterologymedicine.diseasedigestive system diseasesConfidence intervalPancreatic NeoplasmsFNA030220 oncology & carcinogenesisMeta-analysis030211 gastroenterology & hepatologyRadiologyPancreatic CystDifferential diagnosisbusinessDigestive Endoscopy
researchProduct

Evaluation of Borderline Ovarian Tumor Recurrence Rate after Surgery with or without Fertility-Sparing Approach: Results of a Retrospective Analysis

2023

Borderline ovarian tumors (BOTs) comprise 15-20% of primary ovarian neoplasms and represent an independent disease entity among epithelial ovarian cancers. The present study (Clinical Trial ID: NCT05791838) aimed to report a retrospective analysis of the management and outcomes of 86 consecutive BOTs patients, 54 of which were at a reproductive age. All patients with BOTs undergoing surgical treatment from January 2010 to December 2017 were included. Data were retrospectively reviewed. High levels of Ca-125 were observed in 25.6% of the FIGO stage I patients and 58.3% of the advanced disease patients. Fertility-sparing surgery and comprehensive surgical staging were performed in 36.7% and 4…

Fertility-sparing surgeryBorderline ovarian tumorSurgical staging.Conservative surgeryMicropapillary patternSettore MED/40 - Ginecologia E Ostetricia
researchProduct

BRAF mutation influences hypoxia-inducible factor-1α expression levels in papillary thyroid cancer

2010

Hypoxia-inducible factor-1α is found frequently overexpressed in solid tumors cells, exerting an important role in angiogenesis, glucose metabolism, cell proliferation, survival and invasion. In thyroid carcinomas, hypoxia-inducible factor-1α expression was found increased in differentiated, poorly differentiated, medullary and anaplastic variants. Hypoxia represents the principal stimulus responsible for hypoxia-inducible factor-1α induction. Other nonhypoxic stimuli increase hypoxia-inducible factor-1α synthesis through the activation of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in a cell-type-specific manner. We have previously shown the role of BRAFV600…

Gene knockdownPathologymedicine.medical_specialtyMutationCell growthAngiogenesisBiologymedicine.diseasemedicine.disease_causePathology and Forensic MedicinePapillary thyroid cancerThyroid carcinomaCancer researchmedicineSignal transductionPAX8Modern Pathology
researchProduct

Cytogenetic analysis of three primary Bellini duct carcinomas.

1996

Three Bellini duct carcinomas (BDC) of the kidney were cytogenetically analyzed after short-term culture. All three had clonal chromosome abnormalities: 91-92,XXY,-Y, +12, +12, -15, -16, -18, +mar (case 1); 53,XY, +2,t(2;7)(p22;q11), +der (2)t (2;7)(p22;q11), +3, +r(3),add(5)(p15), +7, -8, +12, +17, +r(17), +20, -21 (case 2); and 44-47,X,-Y, +9, +16, -21/46,XY. Some of the numerical abnormalities are shared with papillary renal cell carcinomas (PRCC)(+7, +12, +16, +17, and +20) but not with transitional renal cell carcinomas. The present findings support the previous notion that BDC are different from other types of RCC.

GeneticsAged 80 and overMaleCancer ResearchKidneyPapillary renal cell carcinomasCellBiologyAdenocarcinomaMiddle AgedMolecular biologySurvival AnalysisKidney NeoplasmsDiagnosis Differentialmedicine.anatomical_structureKaryotypingGeneticsmedicineHumansFemaleDuct (anatomy)Carcinoma Renal CellAgedNeoplasm StagingGenes, chromosomescancer
researchProduct